PHARMA MAR SA revenue for the last year amounted to 2.96 B MXN, the most of which — 2.94 B MXN — came from its highest performing source at the moment, Oncology, the year earlier bringing 3.99 B MXN. The greatest contribution to the revenue figure was made by Ireland — last year it brought PHARMA MAR SA 1.41 B MXN, and the year before that — 1.81 B MXN.